Bubs Australia eyes higher sales revenue for 2024 amid organisational review
06/07/2023 24:00
July 6 (Reuters) - Bubs Australia BUB.AX forecast a
35% growth in net sales revenue for fiscal 2024, the infant
formula maker said on Thursday, as it lays a strategic review
outcome.
The company expects to report a net sales revenue of A$80
million ($53.23 million) for the full year.
($1 = 1.5029 Australian dollars)
(Reporting by Rishav Chatterjee in Bengaluru; Editing by Shweta
Agarwal)
((Rishav.Chatterjee@thomsonreuters.com;))
Recent news on Bubs Australia
See all newsBubs Australia hits near two-month low as quarterly revenue declines
Bubs Australia shares set for 15% weekly gain on FDA approval for infant formula products
Bubs Australia extends rally after infant formulas get US FDA approval
Bubs Australia gets permanent FDA nod for infant formula sales in US, shares jump (updated)
Bubs Australia secures permanent FDA nod for infant formula sales in US, shares jump